Home  /  Scientific & Medical Writing  /  Clinical Study Reports
Scientific & Medical Writing · ICH E3

Clinical Study Report (CSR) Writing Services

A clinical study report (CSR) is the definitive document of a completed trial, the complete and unbiased account of how the study was designed, conducted, analysed, and interpreted. EvySaif's clinical study report writing services produce ICH E3 compliant CSRs for Phase 1 through Phase 4 trials, transforming your protocol, statistical analysis plan, and final tables, listings, and figures (TLFs) into a clear, regulator-ready narrative.

ICH E3Phase 1 to 4TLF integrationPatient narratives
CSR · Build
InputsProtocol, SAP, and final TLFs
StructureICH E3 Sections 1 to 15
DraftEfficacy, safety, and discussion
PackageAppendices and submission-ready
The Pathway

Written to ICH E3, applied rather than pasted

The ICH E3 guideline defines the structure and content of a CSR across its recognised sections, from study objectives and methodology through efficacy, safety, and discussion. Importantly, ICH E3 is a guideline, not a rigid template, and its 2012 Question and Answer supplement makes that explicit.

Apply the guideline's flexibility correctly

We follow your company template where you have one, adapt section emphasis to the type of study, and produce a document that is, in the guideline's own intent, complete, unambiguous, well organised, and easy to review.

ICH E32012 Q&A supplement

Coordinate the inputs

A CSR draws on the protocol, the statistical analysis plan, the TLFs, and the narratives. We bring those many inputs into a single coherent document delivered on schedule.

Write it to stand alone

The CSR is written so a reviewer can understand the design, endpoints, and findings without constantly cross-referencing the protocol.

Choose the right report type

Not every study needs a full report. We produce full integrated CSRs, abbreviated and synoptic reports, and shell CSRs you can complete as data matures.

FullAbbreviatedSynopticShell
At a Glance
GuidelineICH E3, with the 2012 Q&A
ScopeICH E3 body, Sections 1 to 15
Trial phasesPhase 1 to 4
Report typesFull, abbreviated, synoptic, shell
NarrativesSerious adverse events and deaths
AuthoritiesFDA, EMA, CDSCO

Who it is for: sponsors, biotech and pharma companies, academic and investigator-initiated trial teams, and CROs needing overflow or specialist CSR authoring. We are a strong fit for smaller sponsors who need experienced CSR writing without a full-time medical writing department.

Deliverables

What we prepare

Full integrated CSRsICH E3 body, Sections 1 to 15, with TLFs integrated from your statistical outputs.

CSR synopsisA standalone summary of objectives, methods, and results.

Abbreviated and synoptic CSRsFor studies that do not require a full report.

Shell CSRsThe structured blueprint you can complete as data matures.

Patient safety narrativesFor serious adverse events and deaths.

Appendices and packagingAppendix preparation per ICH E3 and submission-ready CSR packaging.

Partnership

How EvySaif helps

We transform your protocol, statistical analysis plan, and final TLFs into a clear, regulator-ready narrative. We apply ICH E3 as the guideline it is rather than a rigid template, coordinate every input into one coherent document, and keep language aligned with your protocol and prior submissions.

Apply ICH E3 with your company template and study type in mind
Coordinate the protocol, SAP, TLFs, and narratives
Write the report to stand alone for a reviewer
Keep language consistent with your prior submissions

Why EvySaif

As one of the best research and medical writing consultancies in India, EvySaif pairs clinical depth with regulatory rigour. Our CSR writing is clinician-led, so the interpretation of efficacy and safety data is scientifically sound, not just well formatted. We coordinate the many inputs a CSR requires into a single coherent document delivered on schedule. EvySaif maintains a portfolio CSR built to demonstrate exactly this standard, which we are happy to walk you through.

Questions

Frequently asked questions

ICH E3 (Structure and Content of Clinical Study Reports), with its 2012 Question and Answer supplement, plus your company template and the expectations of your target authority (FDA, EMA, CDSCO).

Yes. For studies that do not require a full report, or for fast-track timelines, we produce abbreviated, synoptic, or shell CSRs without compromising on quality.

Yes. We prepare clinical narratives for serious adverse events and deaths, either within the CSR or as a separate deliverable.

We can begin structuring from the protocol and statistical analysis plan before lock, and draft the results sections once final TLFs are available.

Have a different question?

Tell us about your product, market, and timeline, and a clinician on our team will reply with specifics rather than a sales script.

Request a proposal
Last updated: July 2026. Regulatory forms, portals, and timelines change; specifics are re-verified periodically.

Trial wrapping up?

Tell us about your study and timeline, and we will come back with a scoped CSR proposal.

Request a proposal